VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PIIIP3 Health Partners Inc.
$11.31$37M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPIIIP/E History

PIII logoP3 Health Partners Inc. (PIII) P/E Ratio History

Deep Value

Trading at -0.2x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2021–2021

Current P/E (TTM)
-0.2x
-100% vs 5Y avg
5Y Avg P/E
84.0x
Median 84.0x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
TTM EPS$-15.00
Price$11.31
Earnings YieldN/A
EPS Growth (1Y)16.3%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 23, 2026, P3 Health Partners Inc. (PIII) trades at a price-to-earnings ratio of -0.2x, with a stock price of $11.31 and trailing twelve-month earnings per share of $-15.00.

The current P/E is 100% below its 5-year average of 84.0x. Over the past five years, PIII's P/E has ranged from a low of 84.0x to a high of 84.0x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, PIII trades at a 101% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, PIII trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PIII DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PIII Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-0.2vs22.1
-101%
Below Sector
vs. S&P 500
-0.2vs24.3
-101%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 16% EPS growth (1Y)

PIII P/E vs Peers

Physician platforms and value-based care peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
MOH logoMOHMolina Healthcare, Inc.
$10B22.1Lowest-Best-56%
CVS logoCVSCVS Health Corporation
$129B72.9-Best-62%
HUM logoHUMHumana Inc.
$43B36.7-Best-1%Best
UNH logoUNHUnitedHealth Group Incorporated
$369B30.7-Best-15%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

PIII Historical P/E Data (2021–2021)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2021 Q3-$493.00$5.8784.0x+0%

Average P/E for displayed period: 84.0x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

5+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PIII — Frequently Asked Questions

Quick answers to the most common questions about buying PIII stock.

What is PIII's P/E ratio?

P3 Health Partners Inc. (PIII) trailing twelve-month P/E ratio is -0.2x, based on TTM diluted EPS of $-15.00. The 5-year average P/E is 84.0x and the historical range spans 84.0x to 84.0x.

Is PIII stock overvalued or undervalued?

PIII trades at -0.2x P/E, below its 5-year average of 84.0x. At the 0th percentile of its historical range (84.0x–84.0x), the stock is priced at a discount to its own history.

Is PIII stock expensive?

No, PIII is not expensive on a historical basis. The current P/E of -0.2x is below the 5-year average of 84.0x and sits at the 0th percentile of its valuation range.

What is PIII's historical P/E range?

Over the past 5 years, PIII's P/E ratio has ranged from 84.0x to 84.0x, with a median of 84.0x and an average of 84.0x. The current P/E of -0.2x places the stock at the 0th percentile of this range. Full historical data spans 2021–2021.

How does PIII's P/E compare to the S&P 500?

PIII trades at -0.2x P/E versus the S&P 500 median of 24.3x. The 101% discount to the market suggests lower growth expectations or perceived higher risk.

How does PIII's valuation compare to Healthcare peers?

P3 Health Partners Inc. P/E of -0.2x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is PIII's PEG ratio?

PIII PEG ratio is N/A, based on a P/E of -0.2x and EPS growth of 16.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is PIII's earnings yield?

PIII earnings yield is N/A, the inverse of its -0.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

PIII P/E Ratio History (2021–2021)

Quarterly valuation multiple from closing price and trailing EPS

Current84.0x
Period Avg84.0x
Range84.0x - 84.0x
Change+0%
1 quartersSep 30, 2021 - Sep 30, 2021